Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
”PPTA Europe’s visits with members and stakeholders this past year were a powerful reminder of why our work matters.
Seeing operations up close, meeting teams, walking through facilities and donation centres, and hearing real-world experiences, grounds our policy and advocacy efforts in the realities you navigate every day.
These moments of connection bring clarity to our mission and reinforce the importance of working together.
The insights gained during these visits strengthened connections and sparked new ideas for how we can collectively advance our shared goals.
Building on this momentum is a priority for 2026.
If you are interested in hosting a visit, send me a note.
These in-person exchanges deepen understanding, amplify collaboration, and help ensure our work reflects the needs and experiences of our members.
Let’s make 2026 a year of stronger connections and meaningful progress across our community.
Connected, we are stronger!”
Stay updated with Hemostasis Today.
-
Feb 26, 2026, 12:05Anirban Sen Gupta: PlateChek Links Platelet Status to Hemostasis Outcomes in Whole Blood
-
Feb 25, 2026, 16:47Alan Nurden: Platelet Defects Explain Bleeding in EHDS Patients
-
Feb 25, 2026, 16:40Mohammed Almohammadi: Uniting Leaders in Laboratory Hematology at the 1st Saudi ISLH Joint Conference
-
Feb 25, 2026, 16:37Salihu Asimawu: Inflammation Is Not a Disease – Hats Off to the Heroes Inside Us
-
Feb 25, 2026, 16:34Michael Makris: Biomarin Has Decided to Withdraw Roctavian from the Market
-
Feb 25, 2026, 16:25Tagreed Alkaltham: The Blood Banker Personality
-
Feb 25, 2026, 16:17Sanjay Ahuja: Insightful Talk on 100 Years of VWD by Jorge Di Paola
-
Feb 25, 2026, 15:20Michael Shapiro։ Creating Real Pathways for Trainees in Preventive Cardiology
-
Feb 25, 2026, 15:15Ajay Kumar: Plasma Component Quality Control Standards